Summary & Overview

CPT 11981: Insertion of Long-Term Drug-Delivery Implant

CPT code 11981 covers the insertion of a bioresorbable, biodegradable, or non‑biodegradable implant (such as a capsule or pellet) that contains a drug for long‑term delivery. This code defines a procedural category increasingly relevant as sustained‑release implants expand across specialties including oncology, pain management, ophthalmology, and endocrinology. Nationally, accurate coding for device‑based drug delivery affects claims processing, device tracking, and longitudinal therapy management.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common sites of service, and how the code is used in practice. The publication summarizes payer coverage patterns and benchmarks where available, highlights relevant policy updates affecting reimbursement and prior authorization, and outlines common billing considerations tied to this procedure type.

The report provides practical reference material for billing and compliance teams, including typical care settings, the clinical rationale for long‑term implants, and points of attention for claims submission. Data not available in the input is identified explicitly where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare11981CPTdrug-deliveryimplantationoutpatient-procedurelong-term-therapymedical-deviceprocedure-coding

Billing Code Overview

CPT code 11981 describes the insertion of a bioresorbable, biodegradable, or non–biodegradable implant (for example, a capsule or pellet) that contains a medication for long‑term drug delivery. The procedure involves placing a drug‑containing implant designed to release medication over an extended period to a targeted site.

Service type: Implantation of a drug delivery device for long‑term medication release.
Typical site of service: Outpatient procedure settings such as ambulatory surgery centers or hospital outpatient departments; may also be performed in physician offices equipped for minor surgical procedures.

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with hormone-receptor positive breast cancer completed primary therapy and requires long-term endocrine therapy. The oncology team elects subcutaneous insertion of a slow-release endocrine implant (pellet) to provide continuous systemic therapy. The patient is consented in clinic; pre-procedure vital signs and medication reconciliation are completed. The implant is placed in a minor procedure room or ambulatory surgery center under local anesthesia with sterile technique. The provider documents pre-procedure indications, implant device type (bioresorbable or non-biodegradable), drug name and dose, insertion site, procedural steps, any immediate complications, and post-procedure instructions. Typical billing uses 11981 for placement of the drug delivery implant. The procedure may occur in outpatient clinic procedure rooms, ambulatory surgical centers, or hospital outpatient departments depending on patient comorbidity and institutional policy.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable E/M service by the same physician on the same day of the procedure	Use when a distinct evaluation and management visit is performed the same day as `11981` and it meets E/M documentation requirements.
`52`	Reduced services	Use when the procedure is partially reduced or not completed as originally intended.
`53`	Discontinued procedure	Use when the procedure is started but terminated due to extenuating circumstances.
`59`	Distinct procedural service	Use to indicate a separate procedure or service not usually bundled with `11981` when performed the same day.
`62`	Two surgeons	Use when two surgeons work together as primary surgeons performing distinct portions of the procedure.
`76`	Repeat procedure by same physician	Use if `11981` is repeated later the same day by the same provider.
`77`	Repeat procedure by another physician	Use if `11981` is repeated later the same day by a different provider.
`78`	Unplanned return to the operating/procedure room for a related procedure by the same physician following initial procedure	Use for a related re-entry procedure during the global period for complications.
`79`	Unrelated procedure or service by the same physician during the postoperative period	Use when an unrelated procedure is performed during the global period.
`RT`	Right side	Use when the implant is placed on the right side of the body and laterality is required by payer.
`LT`	Left side	Use when the implant is placed on the left side of the body and laterality is required by payer.
`GA`	Waiver of liability statement on file, no ABN required	Use when the payer has granted prior approval or payment waiver under program rules.
`KX`	Requirements specified in the medical policy have been met	Use when the service meets specific payer policy criteria for coverage.
`Q6`	Service furnished under a global surgical package	Use when billing within a global period and the service is included in a global package.

Taxonomy Code	Specialty	Notes
Data not available in the input.	Data not available in the input.	Data not available in the input.
Data not available in the input.	Data not available in the input.	Data not available in the input.
Data not available in the input.	Data not available in the input.	Data not available in the input.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
Data not available in the input.	Data not available in the input.	Data not available in the input.
Data not available in the input.	Data not available in the input.	Data not available in the input.
Data not available in the input.	Data not available in the input.	Data not available in the input.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11981`	The provider inserts a bioresorbable, biodegradable, or non–biodegradable implant, such as a capsule or pellet, containing a drug for long–term delivery.	Primary procedure code for implantation of a drug-delivery device.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common same-day E/M when a separate, significant evaluation is performed prior to `11981`.
`20610`	Arthrocentesis, aspiration and/or injection, major joint or bursa (e.g., shoulder, knee, hip) — when applicable	May be performed in conjunction if joint access and local drug depot placement are required.
`11900`	Injection, extensive subcutaneous or intramuscular depot/implant of medication (not otherwise specified) — simple injection codes when smaller implantable devices or alternative depot placements are used	Related for alternative methods of long-acting drug delivery when implant placement technique differs.
`36415`	Collection of venous blood by venipuncture	Often performed pre-procedure for lab testing or medication monitoring.
`99024`	Postoperative follow-up visit during a global period, related to the procedure	Used for routine post-op follow-up visits within the global period after `11981`.